Director's Dealing • Sep 22, 2025
Director's Dealing
Open in ViewerOpens in native device viewer
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Soleglad Invest AS | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Close associated enterprise (legal person) to the PDMR, Kathrine Elisabeth Gamborg Andreassen, CEO of Navamedic ASA |
|||
| b) | Initial notification /Amendment | Initial notification | |||
| 3 | Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor |
||||
| a) | Business name | Navamedic ASA | |||
| b) | LEI code | 529900LKVQOR2SRUJU71 | |||
| 4 | Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted |
||||
| a) | Description of the financial instrument/type of instrument Identification code |
Financial instruments/subscription rights linked to shares in Navamedic ASA (ISIN: NO0010205966) ISIN: NO0013629683 |
|||
| b) | Nature of the transaction | Acceptance/receipt of subscription rights | |||
| c) | Price(s) and volume(s) | Currency | Price(s) | Volume(s) | |
| NOK 0 Sum 0 |
0 0 |
264,165 0 |
|||
| d) | Aggregated information - Aggregated volume - Aggregated price |
264,165 subscription rights NOK 0 |
|||
| e) | Date of the transaction | 2025-09-22 | |||
| f) | Place of the transaction | XOFF – Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Lars Hjarrand | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | CFO | |||
| b) | Initial notification /Amendment | Initial notification | |||
| 3 | Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor |
||||
| a) | Business name | Navamedic ASA | |||
| b) | LEI code | 529900LKVQOR2SRUJU71 | |||
| 4 | Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted |
||||
| a) | Description of the financial instrument/type of instrument Identification code |
Financial instruments/subscription rights linked to shares in Navamedic ASA (ISIN: NO0010205966) ISIN: NO0013629683 |
|||
| b) | Nature of the transaction | Acceptance/receipt of subscription rights | |||
| c) | Price(s) and volume(s) | Currency | Price(s) | Volume(s) | |
| NOK 0 |
0 | 121,829 | |||
| 0 Sum |
0 | 0 | |||
| d) | Aggregated information | ||||
| - Aggregated volume |
121,829 subscription rights | ||||
| - Aggregated price |
NOK 0 | ||||
| e) | Date of the transaction | 2025-09-22 | |||
| f) | Place of the transaction | XOFF – Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Jurs AS | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Close associated enterprise (legal person) to the PDMR, Morten Jurs, member of the Board of Directors of Navamedic ASA |
|||
| b) | Initial notification /Amendment | Initial notification | |||
| 3 | Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor |
||||
| a) | Business name | Navamedic ASA | |||
| b) | LEI code | 529900LKVQOR2SRUJU71 | |||
| 4 | Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted |
||||
| a) | Description of the financial instrument/type of instrument Identification code |
Financial instruments/subscription rights linked to shares in Navamedic ASA (ISIN: NO0010205966) ISIN: NO0013629683 |
|||
| b) | Nature of the transaction | Acceptance/receipt of subscription rights | |||
| c) | Price(s) and volume(s) | Currency | Price(s) | Volume(s) | |
| NOK 0 Sum 0 |
0 0 |
7,851 0 |
|||
| d) | Aggregated information - Aggregated volume - Aggregated price |
7,851 subscription rights NOK 0 |
|||
| e) | Date of the transaction | 2025-09-22 | |||
| f) | Place of the transaction | XOFF – Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Astrid T. Bratvedt | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Chief Scientific Officer | |||
| b) | Initial notification /Amendment | Initial notification | |||
| 3 | Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor |
||||
| a) | Business name | Navamedic ASA | |||
| b) | LEI code | 529900LKVQOR2SRUJU71 | |||
| 4 | Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted |
||||
| a) | Description of the financial instrument/type of instrument Identification code |
Financial instruments/subscription rights linked to shares in Navamedic ASA (ISIN: NO0010205966) ISIN: NO0013629683 |
|||
| b) | Nature of the transaction | Acceptance/receipt of subscription rights | |||
| c) | Price(s) and volume(s) | Currency Price(s) Volume(s) |
|||
| NOK 0 0 Sum |
0 0 |
684 0 |
|||
| d) | Aggregated information | ||||
| - Aggregated volume |
684 subscription rights | ||||
| - Aggregated price |
NOK 0 | ||||
| e) | Date of the transaction | 2025-09-22 | |||
| f) | Place of the transaction | XOFF – Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Tranbergkollen Invest AS | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Close associated enterprise (legal person) to the PDMR, Astrid T. Bratvedt, Chief Scientific Officer of Navamedic ASA |
|||
| b) | Initial notification /Amendment | Initial notification | |||
| 3 | Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor |
||||
| a) | Business name | Navamedic ASA | |||
| b) | LEI code | 529900LKVQOR2SRUJU71 | |||
| 4 | Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted |
||||
| a) | Description of the financial instrument/type of instrument Identification code |
Financial instruments/subscription rights linked to shares in Navamedic ASA (ISIN: NO0010205966) ISIN: NO0013629683 |
|||
| b) | Nature of the transaction | Acceptance/receipt of subscription rights | |||
| c) | Price(s) and volume(s) | Currency | Price(s) | Volume(s) | |
| NOK 0 |
0 | 205,398 | |||
| Sum 0 |
0 | 0 | |||
| d) | Aggregated information - Aggregated volume - Aggregated price |
205,398 subscription rights NOK 0 |
|||
| e) | Date of the transaction | 2025-09-22 | |||
| f) | Place of the transaction | XOFF – Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Leikerane AS | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Close associated enterprise (legal person) to the PDMR, Ole Henrik Eriksen, Chief Business Development Officer of Navamedic ASA |
|||
| b) | Initial notification /Amendment | Initial notification | |||
| 3 | Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor |
||||
| a) | Business name | Navamedic ASA | |||
| b) | LEI code | 529900LKVQOR2SRUJU71 | |||
| 4 | Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted |
||||
| a) | Description of the financial instrument/type of instrument Identification code |
Financial instruments/subscription rights linked to shares in Navamedic ASA (ISIN: NO0010205966) ISIN: NO0013629683 |
|||
| b) | Nature of the transaction | Acceptance/receipt of subscription rights | |||
| c) | Price(s) and volume(s) | Currency | Price(s) | Volume(s) | |
| NOK 0 Sum 0 |
0 0 |
171,165 0 |
|||
| d) | Aggregated information - Aggregated volume - Aggregated price |
171,165 subscription rights NOK 0 |
|||
| e) | Date of the transaction | 2025-09-22 | |||
| f) | Place of the transaction | XOFF – Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Ole Henrik Eriksen | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Chief Business Development Officer | |||
| b) | Initial notification /Amendment | Initial notification | |||
| 3 | Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor |
||||
| a) | Business name | Navamedic ASA | |||
| b) | LEI code | 529900LKVQOR2SRUJU71 | |||
| 4 | Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted |
||||
| a) | Description of the financial instrument/type of instrument Identification code |
Financial instruments/subscription rights linked to shares in Navamedic ASA (ISIN: NO0010205966) ISIN: NO0013629683 |
|||
| b) | Nature of the transaction | Acceptance/receipt of subscription rights | |||
| c) | Price(s) and volume(s) | Currency | Price(s) | Volume(s) | |
| NOK 0 |
0 | 25,674 | |||
| Sum 0 |
0 | 0 | |||
| d) | Aggregated information | ||||
| - Aggregated volume |
25,674 subscription rights | ||||
| - Aggregated price |
NOK 0 | ||||
| e) | Date of the transaction | 2025-09-22 | |||
| f) | Place of the transaction | XOFF – Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Karianne Femtehjell Olsen | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Commercial Director CHC & Nutrition | |||
| b) | Initial notification /Amendment | Initial notification | |||
| 3 | Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor |
||||
| a) | Business name | Navamedic ASA | |||
| b) | LEI code | 529900LKVQOR2SRUJU71 | |||
| 4 | Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted |
||||
| a) | Description of the financial instrument/type of instrument Identification code |
Financial instruments/subscription rights linked to shares in Navamedic ASA (ISIN: NO0010205966) ISIN: NO0013629683 |
|||
| b) | Nature of the transaction | Acceptance/receipt of subscription rights | |||
| c) | Price(s) and volume(s) | Currency | Price(s) | Volume(s) | |
| NOK 0 |
0 | 9,508 | |||
| 0 Sum |
0 | 0 | |||
| d) | Aggregated information | ||||
| - Aggregated volume |
9,508 subscription rights | ||||
| - Aggregated price |
NOK 0 | ||||
| e) | Date of the transaction | 2025-09-22 | |||
| f) | Place of the transaction | XOFF – Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Alexander Lidmejer | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | COO | |||
| b) | Initial notification /Amendment | Initial notification | |||
| 3 | Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor |
||||
| a) | Business name | Navamedic ASA | |||
| b) | LEI code | 529900LKVQOR2SRUJU71 | |||
| 4 | Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted |
||||
| a) | Description of the financial instrument/type of instrument Identification code |
Financial instruments/subscription rights linked to shares in Navamedic ASA (ISIN: NO0010205966) ISIN: NO0013629683 |
|||
| b) | Nature of the transaction | Acceptance/receipt of subscription rights | |||
| c) | Price(s) and volume(s) | Currency | Price(s) | Volume(s) | |
| NOK 0 |
0 | 22,981 | |||
| 0 Sum |
0 | 0 | |||
| d) | Aggregated information | ||||
| - Aggregated volume |
22,981 subscription rights | ||||
| - Aggregated price |
NOK 0 | ||||
| e) | Date of the transaction | 2025-09-22 | |||
| f) | Place of the transaction | XOFF – Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Philip Slätis | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Commercial Director RX & International | |||
| b) | Initial notification /Amendment | Initial notification | |||
| 3 | Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor |
||||
| a) | Business name | Navamedic ASA | |||
| b) | LEI code | 529900LKVQOR2SRUJU71 | |||
| 4 | Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted |
||||
| a) | Description of the financial instrument/type of instrument Identification code |
Financial instruments/subscription rights linked to shares in Navamedic ASA (ISIN: NO0010205966) ISIN: NO0013629683 |
|||
| b) | Nature of the transaction | Acceptance/receipt of subscription rights | |||
| c) | Price(s) and volume(s) | Currency | Price(s) | Volume(s) | |
| NOK 0 Sum 0 |
0 0 |
3,423 0 |
|||
| d) | Aggregated information | ||||
| - Aggregated volume |
3,423 subscription rights | ||||
| - Aggregated price |
NOK 0 | ||||
| e) | Date of the transaction | 2025-09-22 | |||
| f) | Place of the transaction | XOFF – Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Jostein Davidsen | ||
| 2 | Reason for the notification | |||
| a) | Position/status | Chairperson of the Board | ||
| b) | Initial notification /Amendment | Initial notification | ||
| 3 | Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor |
|||
| a) | Business name | Navamedic ASA | ||
| b) | LEI code | 529900LKVQOR2SRUJU71 | ||
| 4 | Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted |
|||
| a) | Description of the financial instrument/type of instrument Identification code |
Financial instruments/subscription rights linked to shares in Navamedic ASA (ISIN: NO0010205966) ISIN: NO0013629683 |
||
| b) | Nature of the transaction | Acceptance/receipt of subscription rights | ||
| c) | Price(s) and volume(s) | Currency | Price(s) | Volume(s) |
| NOK 0 Sum 0 |
0 0 |
17,116 0 |
||
| d) | Aggregated information - Aggregated volume - Aggregated price |
17,116 subscription rights NOK 0 |
||
| e) | Date of the transaction | 2025-09-22 | ||
| f) | Place of the transaction | XOFF – Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Åsa Kornfeldt | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Board Member | |||
| b) | Initial notification /Amendment | Initial notification | |||
| 3 | Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor |
||||
| a) | Business name | Navamedic ASA | |||
| b) | LEI code | 529900LKVQOR2SRUJU71 | |||
| 4 | Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted |
||||
| a) | Description of the financial instrument/type of instrument Identification code |
Financial instruments/subscription rights linked to shares in Navamedic ASA (ISIN: NO0010205966) ISIN: NO0013629683 |
|||
| b) | Nature of the transaction | Acceptance/receipt of subscription rights | |||
| c) | Price(s) and volume(s) | Currency | Price(s) | Volume(s) | |
| NOK 0 Sum 0 |
0 0 |
1,362 0 |
|||
| d) | Aggregated information | ||||
| - Aggregated volume |
1,362 subscription rights | ||||
| - Aggregated price |
NOK 0 | ||||
| e) | Date of the transaction | 2025-09-22 | |||
| f) | Place of the transaction | XOFF – Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
|---|---|---|---|---|---|---|
| a) | Name | Edmèe Steenken | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Board Member | ||||
| b) | Initial notification /Amendment | Initial notification | ||||
| 3 | Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor |
|||||
| a) | Business name | Navamedic ASA | ||||
| b) | LEI code | 529900LKVQOR2SRUJU71 | ||||
| 4 | Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted |
|||||
| a) | Description of the financial instrument/type of instrument Identification code |
Financial instruments/subscription rights linked to shares in Navamedic ASA (ISIN: NO0010205966) ISIN: NO0013629683 |
||||
| b) | Nature of the transaction | Acceptance/receipt of subscription rights | ||||
| c) | Price(s) and volume(s) | Currency | Price(s) | Volume(s) | ||
| NOK 0 Sum 0 |
0 0 |
3,423 0 |
||||
| d) | Aggregated information | |||||
| - Aggregated volume |
3,423 subscription rights | |||||
| - Aggregated price |
NOK 0 | |||||
| e) | Date of the transaction | 2025-09-22 | ||||
| f) | Place of the transaction | XOFF – Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
|---|---|---|---|---|---|---|
| a) | Name | Rune Wahl | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Board Member | ||||
| b) | Initial notification /Amendment | Initial notification | ||||
| 3 | Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor |
|||||
| a) | Business name | Navamedic ASA | ||||
| b) | LEI code | 529900LKVQOR2SRUJU71 | ||||
| 4 | Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type pf transaction, iii) each date, and iv) each place where the transaction(s) have been conducted |
|||||
| a) | Description of the financial instrument/type of instrument Identification code |
Financial instruments/subscription rights linked to shares in Navamedic ASA (ISIN: NO0010205966) ISIN: NO0013629683 |
||||
| b) | Nature of the transaction | Acceptance/receipt of subscription rights | ||||
| c) | Price(s) and volume(s) | Currency | Price(s) | Volume(s) | ||
| NOK 0 Sum 0 |
0 0 |
20,539 0 |
||||
| d) | Aggregated information | |||||
| - Aggregated volume |
20,539 subscription rights | |||||
| - Aggregated price |
NOK 0 | |||||
| e) | Date of the transaction | 2025-09-22 | ||||
| f) | Place of the transaction | XOFF – Outside a trading venue |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.